New Perspectives on the Risk of Secondary Cancers After CAR T-cell Therapy
Amidst an FDA investigation into secondary cancers after CAR T therapy, researchers show the risk is likely minimal.
Category: In the News
Amidst an FDA investigation into secondary cancers after CAR T therapy, researchers show the risk is likely minimal.
As hundreds of cancer researchers and patient advocates traveled to Florida for the 16th AACR Conference on the Science...
A long and fruitful partnership in the world of cancer research began in 2006 in Hollywood with AACR CEO...
The numbers are in, and AACR Annual Meeting 2023 was a resounding success. From April 14-19, more than 20,000...
When Monica Bertagnolli, MD, was appointed director of the National Cancer Institute in 2022, she became the first woman...
Two years ago, amid increased awareness of the need to diversify the scientific work force and end cancer health...
World Cancer Day is February 4, 2023. This annual initiative by the Union for International Cancer Control (UICC) aims...
By Cancer Today Staff News stories about efforts to eliminate and prevent cancer often tell the story in broad...
If you toasted 2023 with champagne, then woke up pledging a month of sobriety, you’re not alone. In the...
Amy Bianchi discovered a lump in her breast when her first child was 18 months old. She was diagnosed...